Breaking News Instant updates and real-time market news.

BYND

Beyond Meat

$72.94 /

+5.77 (+8.59%)

05:07
03/26/20
03/26
05:07
03/26/20
05:07

Beyond Meat downgraded to Sell from Neutral at Goldman Sachs

Goldman Sachs analyst Adam Samuelson downgraded Beyond Meat to Sell from Neutral with a price target of $39, down from $129. Beyond Meat represents one of the stocks that is most directly impacted by the COVID-19 outbreak, with over half of its sales into the foodservice channel, Samuelson tells investors in a research note. The analyst believes traffic declines represent a "substantial" near-term sales headwind and sees "meaningful risk" to further foodservice distribution gains in the near-to-medium term, with plant-based menu innovation a "substantially lower priority" for operators in the current environment. Samuelson thinks shares of Beyond Meat can fall 42%.

OTHER BREAKING NEWS FROM THE FLY

Initiation
Deckers Brands initiated with a Buy at Seaport Global » 06:27
01/18/22
01/18
06:27
01/18/22
06:27
DECK

Deckers Brands

$323.85 /

-9.94 (-2.98%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DECK Deckers Brands
$323.85 /

-9.94 (-2.98%)

DECK Deckers Brands
$323.85 /

-9.94 (-2.98%)

12/27/21 Baird
Deckers Brands remains a high conviction buy idea, says Baird
11/30/21 Jefferies
Deckers Brands assumed with a Buy at Jefferies
10/04/21 Wedbush
Wedbush sees several key tailwinds for footwear and apparel sector
10/04/21 Wedbush
Deckers Brands initiated with a Neutral at Wedbush
DECK Deckers Brands
$323.85 /

-9.94 (-2.98%)

Recommendations
Apple price target raised to $200 from $175 at Deutsche Bank » 06:27
01/18/22
01/18
06:27
01/18/22
06:27
AAPL

Apple

$172.97 /

+0.7 (+0.41%)

Deutsche Bank analyst…

Deutsche Bank analyst Sidney Ho raised the firm's price target on Apple to $200 from $175 and keeps a Buy rating on the shares. Considering a "healthy demand backdrop" and Apple's "strong" portfolio across its product lines, the Street estimate for 2022 revenue growth of only 5% is too low with the push-out of some revenue from 2021 already accounting for three percentage points of growth, Ho tells investors in a research note. As such, the analyst believes there is an upward bias to Apple's estimates as we go through the year. While supply chain constraints are a near-term headwind to revenue, Apple's supply chain has improved at a faster pace, with iPhone wait times shortening to only a few days, and that should be enough to drive a "beat-and-raise," Ho says. Further, he thinks Apple shares will "benefit from a flight to quality in an inflationary environment."

ShowHide Related Items >><<
AAPL Apple
$172.97 /

+0.7 (+0.41%)

AAPL Apple
$172.97 /

+0.7 (+0.41%)

01/14/22 Wedbush
Apple pursuing sports content would be 'right move at right time,' says Wedbush
01/14/22 Loop Capital
Apple price target raised to $210 from $165 at Loop Capital
01/14/22 Piper Sandler
Piper ups Apple price target, sees favorable setup for 2022
01/13/22 JPMorgan
Apple to report 'modest' beat to Q1 estimates, says JPMorgan
AAPL Apple
$172.97 /

+0.7 (+0.41%)

AAPL Apple
$172.97 /

+0.7 (+0.41%)

AAPL Apple
$172.97 /

+0.7 (+0.41%)

AAPL Apple
$172.97 /

+0.7 (+0.41%)

AAPL Apple
$172.97 /

+0.7 (+0.41%)

Initiation
Krystal Biotech initiated with a Buy at BofA » 06:26
01/18/22
01/18
06:26
01/18/22
06:26
KRYS

Krystal Biotech

$62.18 /

+1.195 (+1.96%)

BofA analyst Alec…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

06:18 Today BofA
Krystal Biotech initiated with a Buy at BofA
11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 Goldman Sachs
Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs
KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

  • 01
    Dec
  • 03
    Feb
KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

Upgrade
Green Plains upgraded to Outperform from In Line at Evercore ISI » 06:26
01/18/22
01/18
06:26
01/18/22
06:26
GPRE

Green Plains

$32.38 /

-0.48 (-1.46%)

Evercore ISI analyst Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRE Green Plains
$32.38 /

-0.48 (-1.46%)

GPRE Green Plains
$32.38 /

-0.48 (-1.46%)

06:09 Today Evercore ISI
Green Plains upgraded to Outperform from In Line at Evercore ISI
12/08/21 Oppenheimer
Green Plains initiated with an Outperform at Oppenheimer
11/08/21 Credit Suisse
Green Plains price target raised to $49 from $44 at Credit Suisse
11/05/21 BMO Capital
Green Plains price target raised to $52 from $43 at BMO Capital
GPRE Green Plains
$32.38 /

-0.48 (-1.46%)

  • 05
    Aug
  • 25
    Feb
GPRE Green Plains
$32.38 /

-0.48 (-1.46%)

GPRE Green Plains
$32.38 /

-0.48 (-1.46%)

Recommendations
Netflix's price increase larger than anticipated, says KeyBanc » 06:25
01/18/22
01/18
06:25
01/18/22
06:25
NFLX

Netflix

$525.35 /

+6.71 (+1.29%)

KeyBanc analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$525.35 /

+6.71 (+1.29%)

NFLX Netflix
$525.35 /

+6.71 (+1.29%)

05:09 Today Piper Sandler
Piper Sandler remains constructive on Netflix shares into Q4 results
01/14/22 UBS
Netflix price target lowered to $690 from $720 at UBS
01/14/22 Wedbush
Apple pursuing sports content would be 'right move at right time,' says Wedbush
01/13/22 Credit Suisse
Lack of visibility going into Netflix Q4 results, says Credit Suisse
NFLX Netflix
$525.35 /

+6.71 (+1.29%)

NFLX Netflix
$525.35 /

+6.71 (+1.29%)

NFLX Netflix
$525.35 /

+6.71 (+1.29%)

NFLX Netflix
$525.35 /

+6.71 (+1.29%)

Initiation
Westlake Chemical resumed with a Buy at Deutsche Bank » 06:24
01/18/22
01/18
06:24
01/18/22
06:24
WLK

Westlake Chemical

$107.22 /

+2.245 (+2.14%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WLK Westlake Chemical
$107.22 /

+2.245 (+2.14%)

WLK Westlake Chemical
$107.22 /

+2.245 (+2.14%)

11/29/21 Piper Sandler
Westlake Chemical price target raised to $125 from $109 at Piper Sandler
11/22/21 KeyBanc
KeyBanc downgrades Celanese, Olin, Westlake Chemical to Sector Weight
11/22/21 KeyBanc
Westlake Chemical downgraded to Sector Weight from Overweight at KeyBanc
11/03/21 Wells Fargo
Westlake Chemical price target raised to $130 from $125 at Wells Fargo
WLK Westlake Chemical
$107.22 /

+2.245 (+2.14%)

Upgrade
First Republic upgraded to Outperform at Evercore ISI following pullback » 06:22
01/18/22
01/18
06:22
01/18/22
06:22
FRC

First Republic

$192.15 /

-8.39 (-4.18%)

Evercore ISI analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRC First Republic
$192.15 /

-8.39 (-4.18%)

FRC First Republic
$192.15 /

-8.39 (-4.18%)

06:11 Today Evercore ISI
First Republic upgraded to Outperform from In Line at Evercore ISI
01/12/22 UBS
First Republic initiated with a Neutral at UBS
01/10/22 Morgan Stanley
First Republic assumed with an Equal Weight at Morgan Stanley
01/03/22 Barclays
First Republic price target raised to $223 from $215 at Barclays
FRC First Republic
$192.15 /

-8.39 (-4.18%)

  • 10
    Aug
  • 02
    Mar
Recommendations
Lam Research price target raised to $840 from $790 at Berenberg » 06:22
01/18/22
01/18
06:22
01/18/22
06:22
LRCX

Lam Research

$729.90 /

+43.97 (+6.41%)

Berenberg analyst Tammy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRCX Lam Research
$729.90 /

+43.97 (+6.41%)

LRCX Lam Research
$729.90 /

+43.97 (+6.41%)

01/13/22 Mizuho
Lam Research price target raised to $770 from $700 at Mizuho
01/12/22 Barclays
Lam Research price target raised to $750 from $625 at Barclays
01/05/22 Jefferies
Lam Research initiated with a Buy at Jefferies
12/21/21 Wells Fargo
Lam Research price target raised to $660 from $575 at Wells Fargo
LRCX Lam Research
$729.90 /

+43.97 (+6.41%)

LRCX Lam Research
$729.90 /

+43.97 (+6.41%)

LRCX Lam Research
$729.90 /

+43.97 (+6.41%)

LRCX Lam Research
$729.90 /

+43.97 (+6.41%)

Recommendations
Tesla price target raised to $1,025 from $830 at Credit Suisse » 06:22
01/18/22
01/18
06:22
01/18/22
06:22
TSLA

Tesla

$1,049.72 /

+18.72 (+1.82%)

Credit Suisse analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,049.72 /

+18.72 (+1.82%)

TSLA Tesla
$1,049.72 /

+18.72 (+1.82%)

01/12/22 New Street
New Street sees 50% upside in Tesla this year amid 'perfect storm'
01/11/22 Redburn
Redburn starts Lucid Group at Neutral on risks of competing against Tesla
01/10/22 Morgan Stanley
Tesla price target raised to $1,300 from $1,200 at Morgan Stanley
01/10/22 Goldman Sachs
Goldman ups Tesla price target, says best positioned in EVs
TSLA Tesla
$1,049.72 /

+18.72 (+1.82%)

TSLA Tesla
$1,049.72 /

+18.72 (+1.82%)

TSLA Tesla
$1,049.72 /

+18.72 (+1.82%)

TSLA Tesla
$1,049.72 /

+18.72 (+1.82%)

Recommendations
KLA Corp. price target raised to $545 from $470 at Berenberg » 06:22
01/18/22
01/18
06:22
01/18/22
06:22
KLAC

KLA Corp.

$445.18 /

+23.55 (+5.59%)

Berenberg analyst Tammy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLAC KLA Corp.
$445.18 /

+23.55 (+5.59%)

KLAC KLA Corp.
$445.18 /

+23.55 (+5.59%)

01/12/22 Barclays
KLA Corp. price target raised to $425 from $350 at Barclays
01/05/22 Jefferies
KLA Corp. initiated with a Buy at Jefferies
12/21/21
Fly Intel: Top five analyst upgrades
12/21/21 Wells Fargo
KLA Corp. upgraded to Overweight from Equal Weight at Wells Fargo
KLAC KLA Corp.
$445.18 /

+23.55 (+5.59%)

KLAC KLA Corp.
$445.18 /

+23.55 (+5.59%)

KLAC KLA Corp.
$445.18 /

+23.55 (+5.59%)

KLAC KLA Corp.
$445.18 /

+23.55 (+5.59%)

Recommendations
Applied Materials price target raised to $205 from $160 at Berenberg » 06:22
01/18/22
01/18
06:22
01/18/22
06:22
AMAT

Applied Materials

$167.01 /

+9.855 (+6.27%)

Berenberg analyst Tammy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$167.01 /

+9.855 (+6.27%)

AMAT Applied Materials
$167.01 /

+9.855 (+6.27%)

01/13/22 Mizuho
Applied Materials price target raised to $178 from $161 at Mizuho
01/12/22 Barclays
Applied Materials price target raised to $165 from $150 at Barclays
01/05/22 Jefferies
Applied Materials initiated with a Buy at Jefferies
12/15/21 Deutsche Bank
Applied Materials price target raised to $180 from $170 at Deutsche Bank
AMAT Applied Materials
$167.01 /

+9.855 (+6.27%)

AMAT Applied Materials
$167.01 /

+9.855 (+6.27%)

AMAT Applied Materials
$167.01 /

+9.855 (+6.27%)

AMAT Applied Materials
$167.01 /

+9.855 (+6.27%)

Downgrade
Brandywine Realty downgraded to Hold from Buy at Truist » 06:21
01/18/22
01/18
06:21
01/18/22
06:21
BDN

Brandywine Realty

$14.31 /

-0.04 (-0.28%)

Truist analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDN Brandywine Realty
$14.31 /

-0.04 (-0.28%)

04/14/21 Mizuho
Brandywine Realty price target raised to $13 from $12 at Mizuho
03/22/21 Evercore ISI
Evercore downgrades Brandywine Realty to In Line following outperformance
03/22/21 Evercore ISI
Brandywine Realty downgraded to In Line from Outperform at Evercore ISI
BDN Brandywine Realty
$14.31 /

-0.04 (-0.28%)

Recommendations
Citi price target lowered to $85 from $88 at Piper Sandler » 06:19
01/18/22
01/18
06:19
01/18/22
06:19
C

Citi

$66.93 /

-0.89 (-1.31%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
C Citi
$66.93 /

-0.89 (-1.31%)

C Citi
$66.93 /

-0.89 (-1.31%)

01/12/22 JPMorgan
Citi 'continues to dismantle itself,' says JPMorgan
01/06/22 JPMorgan
Citi price target lowered to $76 from $80.50 at JPMorgan
01/03/22 Barclays
Citi price target lowered to $73 from $86 at Barclays
12/15/21 Odeon Capital
Citi upgraded to Buy from Hold at Odeon Capital
C Citi
$66.93 /

-0.89 (-1.31%)

C Citi
$66.93 /

-0.89 (-1.31%)

C Citi
$66.93 /

-0.89 (-1.31%)

C Citi
$66.93 /

-0.89 (-1.31%)

Periodicals
Horta-Osorio lost Credit Suisse board support over Covid rules breach, WSJ says » 06:19
01/18/22
01/18
06:19
01/18/22
06:19
CS

Credit Suisse

$10.55 /

+0.04 (+0.38%)

Antonio Horta-Osorio, who…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

01/07/22 Exane BNP Paribas
Credit Suisse downgraded to Neutral from Outperform at Exane BNP Paribas
01/06/22 JPMorgan
Credit Suisse price target raised to CHF 10.60 from CHF 10.40 at JPMorgan
01/06/22 Keefe Bruyette
Credit Suisse downgraded to Underperform from Market Perform at Keefe Bruyette
12/06/21 UBS
Credit Suisse downgraded to Neutral from Buy at UBS
CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

CS Credit Suisse
$10.55 /

+0.04 (+0.38%)

Downgrade
Duke Realty downgraded to Hold from Buy at Truist » 06:18
01/18/22
01/18
06:18
01/18/22
06:18
DRE

Duke Realty

/

+

Truist analyst Ki Bin Kim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRE Duke Realty
/

+

01/13/22 Mizuho
Duke Realty price target raised to $65 from $50 at Mizuho
01/07/22 BMO Capital
Duke Realty downgraded to Market Perform from Outperform at BMO Capital
12/09/21 BofA
Rexford Industrial added to US 1 List; Duke Realty & Disney removed at BofA
11/19/21 RBC Capital
Duke Realty upgraded to Outperform from Sector Perform at RBC Capital
DRE Duke Realty
/

+

DRE Duke Realty
/

+

Initiation
Krystal Biotech initiated with a Buy at BofA » 06:18
01/18/22
01/18
06:18
01/18/22
06:18
KRYS

Krystal Biotech

$62.18 /

+1.195 (+1.96%)

BofA analyst Alec…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

11/29/21 H.C. Wainwright
Krystal Biotech price target raised to $124 from $103 at H.C. Wainwright
07/20/21
Fly Intel: Top five analyst upgrades
07/20/21 Goldman Sachs
Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs
07/09/21 Chardan
Krystal Biotech coverage transferred at Chardan
KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

  • 01
    Dec
  • 03
    Feb
KRYS Krystal Biotech
$62.18 /

+1.195 (+1.96%)

Initiation
Vtex initiated with an Overweight at Piper Sandler » 06:18
01/18/22
01/18
06:18
01/18/22
06:18
VTEX

Vtex

$7.55 /

-0.175 (-2.27%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTEX Vtex
$7.55 /

-0.175 (-2.27%)

VTEX Vtex
$7.55 /

-0.175 (-2.27%)

04:52 Today Goldman Sachs
Vtex upgraded to Buy from Neutral at Goldman Sachs
09/24/21 Morgan Stanley
Vtex upgraded to Overweight from Equal Weight at Morgan Stanley
08/16/21 JPMorgan
Vtex initiated with a Neutral at JPMorgan
08/16/21 Morgan Stanley
Vtex initiated with an Equal Weight at Morgan Stanley
VTEX Vtex
$7.55 /

-0.175 (-2.27%)

  • 21
    Jul
VTEX Vtex
$7.55 /

-0.175 (-2.27%)

VTEX Vtex
$7.55 /

-0.175 (-2.27%)

Recommendations
JPMorgan price target lowered to $187 from $192 at Piper Sandler » 06:18
01/18/22
01/18
06:18
01/18/22
06:18
JPM

JPMorgan

$157.90 /

-10.415 (-6.19%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$157.90 /

-10.415 (-6.19%)

JPM JPMorgan
$157.90 /

-10.415 (-6.19%)

01/17/22 Keefe Bruyette
JPMorgan price target lowered to $157 from $166 at Keefe Bruyette
01/17/22 Credit Suisse
Credit Suisse keeps $184 target on JPMorgan, says playing the long game
01/14/22 Wells Fargo
Wells Fargo downgrades 'expensive' JPMorgan to Equal Weight on high expenses
01/14/22 Wells Fargo
JPMorgan downgraded to Equal Weight from Overweight at Wells Fargo
JPM JPMorgan
$157.90 /

-10.415 (-6.19%)

JPM JPMorgan
$157.90 /

-10.415 (-6.19%)

JPM JPMorgan
$157.90 /

-10.415 (-6.19%)

JPM JPMorgan
$157.90 /

-10.415 (-6.19%)

Upgrade
Oppenheimer upgrades Six Flags to Outperform with $54 price target » 06:17
01/18/22
01/18
06:17
01/18/22
06:17
SIX

Six Flags

$40.65 /

-0.87 (-2.10%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIX Six Flags
$40.65 /

-0.87 (-2.10%)

SIX Six Flags
$40.65 /

-0.87 (-2.10%)

05:39 Today Oppenheimer
Six Flags upgraded to Outperform from Perform at Oppenheimer
12/17/21 Credit Suisse
Six Flags upgraded to Outperform from Neutral at Credit Suisse
12/14/21 Goldman Sachs
Six Flags upgraded to Buy at Goldman after leisure group correction
12/14/21 Goldman Sachs
Six Flags upgraded to Buy from Neutral at Goldman Sachs
SIX Six Flags
$40.65 /

-0.87 (-2.10%)

SIX Six Flags
$40.65 /

-0.87 (-2.10%)

SIX Six Flags
$40.65 /

-0.87 (-2.10%)

Recommendations
Washington Federal price target raised to $37 from $34 at Piper Sandler » 06:16
01/18/22
01/18
06:16
01/18/22
06:16
WAFD

Washington Federal

$37.49 /

+0.72 (+1.96%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAFD Washington Federal
$37.49 /

+0.72 (+1.96%)

WAFD Washington Federal
$37.49 /

+0.72 (+1.96%)

10/18/21 DA Davidson
Washington Federal price target raised to $39 from $34 at DA Davidson
WAFD Washington Federal
$37.49 /

+0.72 (+1.96%)

WAFD Washington Federal
$37.49 /

+0.72 (+1.96%)

WAFD Washington Federal
$37.49 /

+0.72 (+1.96%)

Hot Stocks
Ford signs five-year payments deal with Stripe » 06:15
01/18/22
01/18
06:15
01/18/22
06:15
F

Ford

$25.19 /

+0.18 (+0.72%)

Ford Motor Company and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
F Ford
$25.19 /

+0.18 (+0.72%)

F Ford
$25.19 /

+0.18 (+0.72%)

01/14/22 RBC Capital
Ford downgraded to Sector Perform at RBC Capital on reduced near-term upside
01/14/22 RBC Capital
Ford downgraded to Sector Perform from Outperform at RBC Capital
01/13/22 Deutsche Bank
Deutsche Bank sees 2022 guidance misses from these auto companies
01/13/22 Deutsche Bank
Ford price target raised to $24 from $18 at Deutsche Bank
F Ford
$25.19 /

+0.18 (+0.72%)

F Ford
$25.19 /

+0.18 (+0.72%)

F Ford
$25.19 /

+0.18 (+0.72%)

F Ford
$25.19 /

+0.18 (+0.72%)

Upgrade
Brixmor upgraded to Buy from Hold at Truist » 06:15
01/18/22
01/18
06:15
01/18/22
06:15
BRX

Brixmor

$26.51 /

-0.27 (-1.01%)

Truist analyst Ki Bin Kim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRX Brixmor
$26.51 /

-0.27 (-1.01%)

01/10/22 Jefferies
Brixmor upgraded to Buy from Hold at Jefferies
12/01/21 Truist
Brixmor price target raised to $26 from $23 at Truist
12/01/21 BMO Capital
Brixmor upgraded to Market Perform from Underperform at BMO Capital
11/19/21 Compass Point
Brixmor upgraded to Buy from Neutral at Compass Point
BRX Brixmor
$26.51 /

-0.27 (-1.01%)

Recommendations
UroGen Pharma price target lowered to $34 from $50 at H.C. Wainwright » 06:15
01/18/22
01/18
06:15
01/18/22
06:15
URGN

UroGen Pharma

$8.49 /

+0.15 (+1.80%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
URGN UroGen Pharma
$8.49 /

+0.15 (+1.80%)

URGN UroGen Pharma
$8.49 /

+0.15 (+1.80%)

04/27/21 H.C. Wainwright
UroGen Pharma price target lowered to $50 from $57 at H.C. Wainwright
URGN UroGen Pharma
$8.49 /

+0.15 (+1.80%)

Upgrade
Limelight Networks upgraded to Buy from Hold at Truist » 06:14
01/18/22
01/18
06:14
01/18/22
06:14
LLNW

Limelight Networks

$3.49 /

+0.025 (+0.72%)

Truist analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLNW Limelight Networks
$3.49 /

+0.025 (+0.72%)

LLNW Limelight Networks
$3.49 /

+0.025 (+0.72%)

12/20/21 Raymond James
Limelight Networks upgraded to Strong Buy from Market Perform at Raymond James
10/15/21 Craig-Hallum
Limelight Networks upgraded to Buy from Hold at Craig-Hallum
10/15/21 Craig-Hallum
Limelight Networks upgraded to Buy from Hold at Craig-Hallum
08/09/21 Raymond James
Limelight Networks reinstated with a Market Perform at Raymond James
LLNW Limelight Networks
$3.49 /

+0.025 (+0.72%)

LLNW Limelight Networks
$3.49 /

+0.025 (+0.72%)

LLNW Limelight Networks
$3.49 /

+0.025 (+0.72%)

Recommendations
Rockwell Medical price target lowered to $3 from $5 at H.C. Wainwright » 06:13
01/18/22
01/18
06:13
01/18/22
06:13
RMTI

Rockwell Medical

/

+

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RMTI Rockwell Medical
/

+

RMTI Rockwell Medical
/

+

02/08/21 H.C. Wainwright
Rockwell Medical price target lowered to $5.50 from $9 at H.C. Wainwright

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.